This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

Professionals 221 Users Online

Franz Cell and Vapometer Market

Market Study on Franz Cells and Vapometers: Nearly 50% End Use Market Share Held by Pharmaceutical Companies

Franz Cell and Vapometer Market Segmented By Jacketed Franz Cells, Unjacketed Franz Cells, Vapometer Devices, Franz Cell Adaptors Product in Pharmaceutical Companies, Academic & Research Institutes, CROs/CDMOs

Franz Cell and Vapometer Market Outlook (2022-2032)

Global revenue from the Franz cell and vapometer market was US$ 6,670.2 Th in 2021, with the worldwide market estimated to progress at a value CAGR of 3.4% to reach US$ 9,538.0 Th by the end of 2032.

According to Persistence Market Research, the Franz cells product type segment ended up with a market value of US$ 6,339.8 Th at the end of 2021.

Franz Cell and Vapometer Market Size (2022)

US$ 6,844.5 Th

Projected Market Value (2032)

US$ 9,538 Th

Global Market Growth Rate (2022-2032)

3.4% CAGR

Market Share of Top 5 Countries

56.9%

Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

Franz Cell and Vapometer Sales Analysis (2012 to 2021) Vs. Market Outlook (2022 to 2032)

The global market for Franz cells and vapometers recorded a historic CAGR of 1.8% over the last 9 years from 2012 to 2021.

Due to the advantages offered by the transdermal route of drug delivery, there has been an increase in the use of transdermal drugs. The usage of these transdermal drugs is directly proportional to the need for the development of transdermal drugs for various indications such as hypertension, bladder muscle dysfunction, menopausal symptoms, and others.

Subsequently, this increase in development surges the number of in-vitro permeation studies that are supported by Franz cells.

Since the transdermal route of administration is not invasive and acts as an aid in eliminating the exposure of first pass metabolism, there is an increase in the adoption of transdermal drug products. These can easily be self-administered when compared to intravenous injections. It is very convenient for patients to apply any type of transdermal drug products such as gels, emulsions, and transdermal patches.

Apart from this, the rise in regulatory approvals of transdermal drug products provides a positive aspect for the growth of the Franz cell and vapometer market. The approval of these transdermal drugs relies on drug formulations that are verified through the in-vitro testing of the skin absorption by using Franz diffusion cells.

There are numerous transdermal drugs and products that have been approved by regulatory bodies such as FDA.

  • For instance, in 2019, FDA approved the first transdermal patch of the atypical antipsychotic drug asenapine for the treatment of schizophrenia in adults. This product was developed by Noven Pharmaceuticals.

The global Franz cell and vapometer market is expected to progress at a value CAGR of 3.4% and reach US$ 9,538 Th by 2032.

franz-cell-and-vapometer-market

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

Why is the Franz Cell and Vapometer Market Expanding Steadily?

Rapidly Increasing Adoption of Transdermal Drug Products across Various Indications to Push Market Growth

Transdermal drug products have seen increased usage for various health conditions such as osteoporosis, contraception, chronic pain, nausea, and vomiting caused due to chemotherapy, neurological disorders such as attention-deficit hyperactivity disorder, depressive disorders, and many others.

Franz cells and vapometers are extensively being used for the evaluation of the degree of efficiency of transdermal drugs.

When it comes to the cosmetics industry, the application of transdermal drugs is pretty high. It is easier for people to apply topical solutions on their skin wherever required on being advised to do so. It is very important to evaluate the active ingredients in these transdermal drugs, and that is where the role of Franz cells and vapometers comes into play.

These Franz cell systems are designed to imitate the behavior of actives and formulations when applied to the skin. This increase in demand represents the growth of the Franz cell and vapometer market.

At present, significant increase in the number of pharmaceutical companies is because of the rising global disease burden. Rise in the number of pharmaceutical companies points to the abundance of opportunities present for the development of novel transdermal drugs. The reason for this increase would be the advantages that are being offered by the transdermal route of administration.

  • For instance, as per the International Federation of Pharmaceutical Manufacturers and Associations Facts and Figures 2021, there were around 2,740 cancer drugs, 1,535 immunology drugs, 1,498 neurology drugs, and 1,213 infectious disease drugs in development in 2020.
Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Are There Any Barriers to Market Expansion?

Skin Acts as Barrier in Development of Transdermal Drugs

The physiology of the skin acts as a barrier to the optimized penetration and permeation of transdermal drugs. These barriers are characterized as mechanical barriers; for example, stratum corneum, tight junctions, etc. This stratum corneum constitutes dead keratinocytes and lipids, which form a molecular architecture that the drug molecules need to permeate to be effective. The barrier function of the skin is calculated using the transepidermal water loss measurement device, such as a vapometer.

Researchers focus on the development of such drugs can be successful. These strategies are none other than enhancement methods used for increasing the penetration and permeation capabilities of transdermal drug products. Enhancement methods include vesicles and particles, energy-driven methods, stratum corneum modification, and drug or vehicle interactions.

Since these barriers restrict the progress of the development of transdermal drugs, this may hamper market growth to some extent.

Prerna Shiv

Prerna Shiv
Client Partner

Let's Connect

Conect me to identify wining opportunities

Ask An Expert
I'm Available

Country-wise Insights

Why is the U.S. Franz Cell and Vapometer Market So Far Ahead?

“Rising Number of Approvals of Transdermal Drugs by FDA”

The U.S. accounted for 93.6% market share in the North America Franz cell and vapometer market in 2021.

Due to the advantageous nature of the transdermal route of administration, the adoption of transdermal drug products and transdermal drug delivery systems is quite high, which shows inflation in the number of transdermal drugs available in the market.

The presence of various manufacturers such as PremeGear Inc. and Logan Instruments Corp. and distributors such as MSP Corporation is quite high in the U.S. This has boosted the availability of products in the Franz cell and vapometer market.

How is China Emerging as a Prominent Market for Franz Cells and Vapometers?

“Increasing Adoption of Transdermal Drug Delivery in China”

China held the largest market share of 43.1% of the East Asia Franz cell and vapometer market in 2021.

As there are various advantages that the administration of transdermal drug delivery systems bring forward, such as minimal side effects, minimizing the frequency of dosing, and others, it is considered more adaptable than the intravenous and intramuscular route of administration.

  • The pain branch of the Chinese Medical Association has formed a consensus so that it can regulate the use of transdermal patches constituting analgesic drugs.

The testing of these drugs is supported by Franz cells, which has a positive impact on the China Franz cell and vapometer market.

Category-wise Insights

Why is the Drug Delivery Segment Expected to Drive High Market?

“Rising Number of Permeation and Penetration Studies”

The Franz cell (for transdermal drug delivery) segment held 95% share of the overall market in 2021.

Increasing interest in transdermal drug products is due to the beneficial characteristics of the transdermal route of administration. This has increased the number of permeation and penetration studies that are conducted to ensure whether transdermal drugs would be able to penetrate and permeate the skin with the right quantity.

The Franz cell is a key apparatus for permeation and penetration studies, thus holding a dominant market share.

Which End User Accounts for Higher Adoption of Franz Cells and Vapometers?

“Pharmaceutical Companies Lead the Way”

Pharmaceutical companies held a high share of 49% with a market value of US$ 3,266.2 Th in 2021.

It is pharmaceutical companies that fulfill the requirements of transdermal drugs. Increasing research and development of transdermal drugs is associated with researchers working in pharmaceutical companies.

Hence, demand for Franz cells is more from pharmaceutical companies when compared to other end users.

Competitive Landscape

To strengthen their presence around the world, key players in the Franz cell and vapometer market are increasing their number of distributors. For example, Canadian Sales Center (Logan Instruments Corp.) in North America, Jover Scientech, S.L. in Europe, Diafana Representaciones in Latin America, Meganede CC in the Middle East and Africa, and many others in other regions.

Another significant approach noticed in the industry is the inclination toward providing top-class technical support and services to customers, as well as the adoption of a sustainable growth approach.

For instance:

  • In 2020, Welch Materials Inc. was appointed as a distributor of Copley Scientific for expanding the sales of the company’s products in the East Asian region, especially China.
  • Teledyne Technologies aims to reduce around 40% of its greenhouse gas emissions starting from 2020 to the end of 2040 as a part of the various clean and green activities to ensure environmental sustainability.

Franz Cell and Vapometer Industry Report Scope

Attribute

Details

Forecast Period

2022-2032

Historical Data Available for

2012-2021

Market Analysis

USD Thousand for Value

Key Countries Covered

  • U.S.
  • Canada
  • Brazil
  • Argentina
  • Mexico
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Russia
  • Nordic Countries
  • BENELUX
  • Nordic countries
  • India
  • Thailand
  • Indonesia
  • Malaysia
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Turkey
  • GCC Countries
  • Northern Africa
  • South Africa

Key Market Segments Covered

  • Product
  • End User
  • Region

Key Companies Profiled

  • Delfin Technologies
  • Biox Systems Ltd.
  • PermeGear, Inc.
  • Orchid Scientific & Innovative India Pvt Ltd.
  • Xenometrix AG
  • Copley Scientific
  • Teledyne Technologies
  • JN SCIENCETECH
  • Logan Instruments Corp.
  • Henkel AG & Co. KGaA

Report Coverage

  • Market Forecast
  • Competition Intelligence
  • DROT Analysis
  • Market Dynamics and Challenges
  • Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Key Segments Covered in Franz Cell and Vapometer Industry Research

Franz Cell and Vapometer Market by Product:

  • Franz Cells (for transdermal drug delivery)
    • Jacketed Franz Cells
    • Unjacketed Franz Cells
  • Vapometers
    • Vapometer Devices
      • Vapometer Devices Used in Franz Cells
      • Others
    • Franz Cell Adaptors

Franz Cell and Vapometer Market by End User:

  • Pharmaceutical Companies
  • Academic & Research Institutes
  • CROs/CDMOs

Franz Cell and Vapometer Market by Region:

  • North America Franz Cell and Vapometer Market
  • Latin America Franz Cell and Vapometer Market
  • Europe Franz Cell and Vapometer Market
  • South Asia Franz Cell and Vapometer Market
  • East Asia Franz Cell and Vapometer Market
  • Oceania Franz Cell and Vapometer Market
  • Middle East & Africa (MEA) Franz Cell and Vapometer Market

- Companies Covered in This Report -

  • Delfin Technologies
  • Biox Systems Ltd.
  • PermeGear, Inc.
  • Orchid Scientific & Innovative India Pvt Ltd.
  • Xenometrix AG
  • Copley Scientific
  • Teledyne Technologies
  • JN SCIENCETECH
  • Logan Instruments Corp.
  • Henkel AG & Co. KGaA

- Frequently Asked Questions -

The global Franz cell and vapometer market was valued at US$ 6,670.2 Th in 2021.

Revenue from Franz cells and vapometers is set to increase at 3.4% CAGR and reach US$ 9,538.0 Th by 2032.

Demand for Franz cells and vapometers increased at 1.8 % CAGR from 2012 to 2021.

The U.S., China, Germany, India, and U.K. account for most demand for Franz cell and vapometer products, currently holding 56.9% market share.

The U.S. accounted for 93.6% share of the North American market in 2021.

Henkel AG & Co. KGaA, Teledyne Instruments, Inc., and XENOMETRIX AG are the top three manufacturers of Franz cells and vapometers.

The Europe market is predicted to expand at 3.5% CAGR over the decade.

China held 43.1% market share in East Asia in 2021, while Japan accounted for 34.3% share.

The U.K. market held 19.8% share in the Europe Franz cell and vapometer market in 2021.

Google translate